Chemical formula: C₁₂H₁₂N₂O₃ Molecular mass: 232.235 g/mol PubChem compound: 4763
Phenobarbital has sedative effects and has some protective action against all varieties of human partial and generalised epilepsy, with the exception of absence seizures. Phenobarbital is also effective in preventing seizures in the corresponding experimental animal models of epilepsy.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N03AA02 | Phenobarbital | N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AA Barbiturates and derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| PHENOBARBITAL SODIUM Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| PHENOBARBITAL ACCORD Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Phenobarbital is an active ingredient of these brands:
Croatia (HR)Estonia (EE)Hong Kong (HK)
Israel (IL)Japan (JP)Lithuania (LT)Romania (RO)
South Africa (ZA)
Spain (ES)Tunisia (TN)Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
